Page last updated: 2024-08-24

gemcitabine and Weight Gain

gemcitabine has been researched along with Weight Gain in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aragno, M; Canuto, RA; Catalano, MG; Fadda, M; Finocchiaro, C; Fortunati, N; Maggiora, M; Monge, T; Muzio, G; Oraldi, M; Pugliese, M; Schena, M; Scigliano, M; Segre, O; Tinivella, M; Tiozzo, E	1
Bespalov, VG; Filatova, LV; Gershanovich, ML; Kon'kov, SA; Krylova, IM; Latipova, DKh; Murazov, IaG; Panchenko, AV; Semiglazova, TIu; Stukov, AN; Tarasenkova, AA; Vershinina, SF	1
Androulakis, N; Aravantinos, G; Athanasiadis, A; Fountzilas, G; Georgoulias, V; Papakotoulas, P; Polyzos, A; Potamiannou, A; Rigatos, SK; Stathopoulos, GP; Syrigos, K; Tsiakopoulos, I; Ziras, N	1

Trials

2 trial(s) available for gemcitabine and Weight Gain

Article	Year
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. The British journal of nutrition, 2012, Volume: 108, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gemcitabine; Humans; Interleukin-6; Lung Neoplasms; Male; Oxidative Stress; Patient Dropouts; Weight Gain	2012
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pancreatic Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome; Weight Gain	2004

Article

Year

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

The British journal of nutrition, 2012, Volume: 108, Issue:2

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gemcitabine; Humans; Interleukin-6; Lung Neoplasms; Male; Oxidative Stress; Patient Dropouts; Weight Gain

2012

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2

Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pancreatic Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome; Weight Gain

2004

Other Studies

1 other study(ies) available for gemcitabine and Weight Gain

Article	Year
[Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor]. Voprosy onkologii, 2011, Volume: 57, Issue:6 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Deoxycytidine; Drug Administration Schedule; Drug Synergism; Female; Gemcitabine; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Time Factors; Triazines; Weight Gain	2011

Article

Year

[Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor].

Voprosy onkologii, 2011, Volume: 57, Issue:6

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Deoxycytidine; Drug Administration Schedule; Drug Synergism; Female; Gemcitabine; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Time Factors; Triazines; Weight Gain

2011